Qure.ai receives regulatory clearance for AI tool for early detection of TB in children below 3 years
Breakthrough expands proactive TB screening from birth to 15 years, ensuring faster and more accurate diagnosis
Breakthrough expands proactive TB screening from birth to 15 years, ensuring faster and more accurate diagnosis
Medroxyprogesterone acetate-SC is a three-month contraceptive that can be administered by healthcare workers or self-injected after appropriate training
Updated indication expands treatment options for patients with ulcerative colitis and Crohn’s disease when tumor necrosis factor (TNF) blockers are clinically inadvisable
New test expands access to early Alzheimer’s assessment, streamlining diagnostic pathways and improving referral efficiency
Acquisition expands Novo Nordisk’s leadership in obesity-related comorbidities and metabolic diseases
Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with potential best-in-class profile for autoimmune diseases
Investment to expand manufacturing and global medicine supply capacity
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
An estimated 50% of patients with ER+, HER2– metastatic breast cancer will develop an ESR1 mutation during or after exposure to an aromatase inhibitor
Subscribe To Our Newsletter & Stay Updated